Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Northeastern Clinical Research Alliance (NECRA) is a specialized clinical research organization (CRO) and site management organization (SMO) dedicated to oncology. The company operates a network of community-based oncology practices across the Northeastern United States, facilitating Phase I through Phase IV clinical trials for pharmaceutical and biotechnology sponsors. NECRA provides end-to-end clinical trial management services, including site identification, regulatory compliance, patient enrollment, and data management. Their mission is to bring cutting-edge cancer treatments to patients in a community setting while ensuring high-quality data for drug developers. By bridging the gap between sponsors and community physicians, the alliance aims to increase patient access to innovative cancer therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Northeastern Clinical Research Alliance of Oncology.